Flaig TW, Tangen CM, Daneshmand S, Alva AS, et al. Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695). Eur Urol 2023 Jul 4:S0302-2838(23)02945-7. doi: 10.1016/j.eururo.2023.
PMID: 37414705